Multi-omics in stress and health research: study designs that will drive the field forward
- PMID: 38425100
- PMCID: PMC11216062
- DOI: 10.1080/10253890.2024.2321610
Multi-omics in stress and health research: study designs that will drive the field forward
Abstract
Despite decades of stress research, there still exist substantial gaps in our understanding of how social, environmental, and biological factors interact and combine with developmental stressor exposures, cognitive appraisals of stressors, and psychosocial coping processes to shape individuals' stress reactivity, health, and disease risk. Relatively new biological profiling approaches, called multi-omics, are helping address these issues by enabling researchers to quantify thousands of molecules from a single blood or tissue sample, thus providing a panoramic snapshot of the molecular processes occurring in an organism from a systems perspective. In this review, we summarize two types of research designs for which multi-omics approaches are best suited, and describe how these approaches can help advance our understanding of stress processes and the development, prevention, and treatment of stress-related pathologies. We first discuss incorporating multi-omics approaches into theory-rich, intensive longitudinal study designs to characterize, in high-resolution, the transition to stress-related multisystem dysfunction and disease throughout development. Next, we discuss how multi-omics approaches should be incorporated into intervention research to better understand the transition from stress-related dysfunction back to health, which can help inform novel precision medicine approaches to managing stress and fostering biopsychosocial resilience. Throughout, we provide concrete recommendations for types of studies that will help advance stress research, and translate multi-omics data into better health and health care.
Keywords: Life stress; development; health; interventions; multi-omics; resilience.
Conflict of interest statement
Disclosure statement
MPS is a cofounder and scientific advisor of Personalis, SensOmics, Qbio, January Ai, Fodsel, Filtricine, Protos, RTHM, Iollo, Marble Therapeutics, Crosshair Therapeutics, and Mirvie. He is a scientific advisor for Jupiter, Neuvivo, Swaza, and Mitrix. The other authors declare no conflicts of interest with respect to this work.
Figures
References
-
- Acharjee A, Larkman J, Cardoso VR, & Gkoutos GV (2020). PowerTools: A web based user-friendly tool for future translational study design. [Preprint]. 10.21203/rs.2.23833/v1 - DOI
-
- Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ, Crawford GE, Jaffe AE, Pinto D, Dracheva S, Geschwind DH, Mill J, Nairn AC, Abyzov A, Pochareddy S, Prabhakar S, Weissman S, Sullivan PF, State MW, Weng Z, … Sestan N (2015). The PsychENCODE project. Nature Neuroscience, 18(12), 1707–1712. Article 12. 10.1038/nn.4156 - DOI - PMC - PubMed
-
- Álvarez-López MJ, Conklin QA, Cosín-Tomás M, Shields GS, King BG, Zanesco AP, Kaliman P, & Saron CD (2022). Changes in the expression of inflammatory and epigenetic-modulatory genes after an intensive meditation retreat. Comprehensive Psychoneuroendocrinology, 11, 100152. 10.1016/j.cpnec.2022.100152 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical